TERC Identified as a Probable Target within the 3q26 Amplicon That Is Detected Frequently in Non-Small Cell Lung Cancers

Clinical Cancer Research

Volumn 9, Issue 13, 2003, Pages 4705-4713

  Yokoi, Sana ^a,b   Yasui, Kohichiroh ^a,c   Iizasa, Toshihiko ^b   Imoto, Issei ^a,c   Fujisawa, Takehiko ^b   Inazawa, Johji ^a,c  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

AMPLICON; ARTICLE; CHROMOSOME 3Q; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TERC GENE;

BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; DNA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MODELS, GENETIC; NUCLEIC ACID HYBRIDIZATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TELOMERASE; UP-REGULATION;

EID: 0142157144     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Takahashi, T. Lung cancer: an ever increasing store of in-depth basic knowledge and the beginning of its clinical application. Oncogene, 21: 6868-6869, 2002.
2. Shinomiya, T., Mori, T., Ariyama, Y., Sakabe, T., Fukuda, Y., Murakami, Y., Nakamura, Y., and Inazawa, J. Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DPI gene in the 13q34 amplicon. Genes Chromosomes Cancer, 24: 337-344, 1999.
3. Fukuda, Y., Kurihara, N., Imoto, I., Yasui, K., Yoshida, M., Yanagihara, K., Park, J. G., Nakamura, Y., and Inazawa, J. CD44 is a potential target of amplification within the 11p13 amplicon detected in gastric cancer cell lines. Genes Chromosomes Cancer, 29: 315-324, 2000.
4. Yang, Z. Q., Imoto, I., Fukuda, Y., Pimkhaokham, A., Shimada, Y., Imamura, M., Sugano, S., Nakamura, Y., and Inazawa, J. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res., 60: 4735-4739, 2000.
5. Yasui, K., Imoto, I., Fukuda, Y., Pimkhaokham, A., Yang, Z. Q., Naruto, T., Shimada, Y., Nakamura, Y., and Inazawa, J. Identification of target genes within an amplicon at 14q 12-q13 in esophageal squamous cell carcinoma. Genes Chromosomes Cancer, 32: 112-118, 2001.
6. Imoto, I., Yang, Z. Q., Pimkhaokham, A., Tsuda, H., Shimada, Y., Imamura, M., Ohki, M., and Inazawa, J. Identification of clAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. Cancer Res., 61: 6629-6634, 2001.
7. Yasui, K., Arii, S., Zhao, C., Imoto, I., Ueda, M., Nagai, H., Emi, M., and Inazawa, J. TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas. Hepatology, 35: 1476-1484, 2002.
8. Yokoi, S., Yasui. K., Saito-Ohara, F., Koshikawa, K., Iizasa, T., Fujisawa, T., Terasaki, T., Horii, A., Takahashi, T., Hirohashi, S., and Inazawa, J. A novel target gene, SKP2, within the 5p 13 amplicon that is frequently detected in small cell lung cancers. Am. J. Pathol., 161: 207-216, 2002.
9. Brass, N., Ukena, I., Remberger, K., Mack, U., Sybrecht, G. W., and Meese, E. U. DNA amplification on chromosome 3q26.1-q26.3 in squamous cell carcinoma of the lung detected by reverse chromosome painting. Eur. J. Cancer, 32: 1205-1208, 1996.
10. Balsara, B. R., Sonoda, G., du Manoir, S., Siegfried, J. M., Gabrielson, E., and Testa, J. R. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res., 57: 2116-2120, 1997.
11. Petersen, I., Bujard, M., Petersen, S., Wolf, G., Goeze, A., Schwendel, A., Langreck, H., Gellert, K., Reichel, M., Just, K., du Manoir, S., Cremer, T., Dietel, M., and Ried, T. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res., 57: 2331-2335, 1997.
12. Bjorkqvist, A. M., Husgafvel-Pursiainen, K., Anttilam, S., Karjalainen, A., Tammilehto, L., Mattson, K., Vainio, H., and Knuutila, S. DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma. Genes Chromosomes Cancer, 22: 79-82, 1998.
13. Balsara, B. R., and Testa, J. R. Chromosomal imbalances in human lung cancer. Oncogene, 21: 6877-6683, 2002.
14. Knuutila, S., Björkvist, A. M., Autio, K., Tarkkanen, M., Wolf, M., Monni, O., Szymanska, J., Larramendy, M. L., Tapper, J., Pere, H., El-Rifai, W., Hemmer, S., Wasenius, V. M., Vidgren, V., and Zhu, Y. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am. J. Pathol., 152: 1107-1123, 1998.
15. Rooney, P. H., Murray, G. I., Stevenson, D. A., Haites, N. E., Cassidy, J., and McLeod, H. L. Comparative genomic hybridization and chromosomal instability in solid tumours. Br. J. Cancer, 80: 862-873, 1999.
16. Heselmeyer, K., Schrock, E., du Manoir, S., Blegen, H., Shah, K., Steinbeck, R., Auer, G., and Ried, T. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc. Natl. Acad. Sci. USA, 93: 479-484, 1996.
17. Singh, B., Stoffel, A., Gogineni, S., Poluri, A., Pfister, D. G., Shaha, A. R., Pathak, A., Bosl, G., Cordon-Cardo, C., Shah, J. P., and Rao, P. H. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas. Am. J. Pathol., 161: 365-371, 2002.
18. Imoto, I., Pimkhaokham, A., Fukuda, Y., Yang, Z. Q., Shimada, Y., Nomura, N., Hirai, H., Imamura, M., and Inazawa, J. SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus. Biochem. Biophys. Res. Commun., 286: 559-565, 2001.
19. Shayesteh, L., Lu, Y., Kuo, W. L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, B., Mills, G. B., and Gray, J. W. PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet., 21: 99-102, 1999.
20. Massion, P. P., Kuo, W. L., Stokoe, D., Olshen, A. B., Treseler, P. A., Chin, K., Chen, C., Polikoff, D., Jain, A. N., Pinkel, D., Albertson, D. G., Jablons, D. M., and Gray, J. W. Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. Cancer Res., 62: 3636-3640, 2002.
21. Soder, A. I., Hoare, S. F., Muir, S., Going, J. J., Parkinson, E. K., and Keith, W. N. Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene, 14: 1013-1021, 1997.
22. Morishita, K., Parganas, E., William, C. L., Whittaker, M. H., Drabkin, H., Oval, J., Taetle, R., Valentine, M. B., and Ihle, J. N. Activation of EV11 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc. Natl. Acad. Sci. USA, 89: 3937-3941, 1992.
23. Ogawa, S., Kurokawa, M., Tanaka, T., Mitani, K., Inazawa, J., Hangaishi, A., Tanaka, K., Matsuo, Y., Minowada, J., Tsubota, T., Yazaki, Y., and Hirai, H. Structurally altered Evi-1 protein generated in the 3q21q26 syndrome. Oncogene, 13: 183-191, 1996.
24. Feng, J., Funk, W. D., Wang, S. S., Weinrich, S. L., Avilion, A. A., Chiu, C. P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, W. H., Greider, C. W., and Villeponteau, B. The RNA component of human telomerase. Science (Wash. DC), 269: 1236-1241, 1995.
25. Kallioniemi, A., Kallioniemi, O. P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., and Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (Wash. DC), 258: 818-821, 1992.
26. Ariyama, Y., Mori, T., Shinomiya, T., Sakabe, T., Fukuda, Y., Kanamaru, A., Yamada, Y., Isobe, M., Seto, M., Nakamura, Y., and Inazawa, J. Chromosomal imbalances in adult T-cell leukemia revealed by comparative genomic hybridization: gains at 14q32 and 2p16-22 in cell lines. J. Hum. Genet., 44: 357-363, 1999.
27. Inazawa, J., Saito, H., Ariyama, T., Abe, T., and Nakamura, Y. High-resolution cytogenetic mapping of 342 new cosmid markers including 43 RFLP markers on human chromosome 17 by fluorescence in situ hybridization. Genomics, 17: 153-162, 1993.
28. Kurokawa, M., Mitani, K., Irie, K., Matsuyama, T., Takahashi, T., Chiba, S., Yazaki, Y., Matsumoto, K., and Hirai, H. The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3. Nature (Lond.), 394: 92-96, 1998.
29. Nomura, N., Sasamoto, S., Ishii, S., Date, T., Matsui, M., and Ishizaki, R. Isolation of human cDNA clones of ski and the ski-related gene, sno. Nucleic Acids Res., 17: 5489-5500, 1989.
30. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Wash. DC), 266: 2011-2015, 1994.
31. Shay, J. W., Zou, Y., Hiyama, E., and Wright, W. E. Telomerase and cancer. Hum. Mol. Genet., 10: 677-685, 2001.
32. Soder, A. I., Going, J. J., Kaye, S. B., and Keith, W. N. Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization. Oncogene, 16: 979-983, 1998.
33. Avilion, A. A., Piatyszek, M. A., Gupta, J., Shay, J. W., Bacchetti, S., and Greider, C. W. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res., 56: 645-650, 1996.
34. Blasco, M. A., Rizen, M., Greider, C. W., and Hanahan, D. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat. Genet., 12: 200-204, 1996.
35. Liu, J. P. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J., 13: 2091-2104, 1999.
36. Zhou, X. Z., and Lu, K. P. The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell, 107: 347-359, 2001.
37. Pei, J., Balsara, B. R., Li, W., Litwin, S., Gabrielson, E., Feder, M., Jen, J., and Testa, J. R. Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas. Genes Chromosomes Cancer, 31: 282-287, 2001.
38. Brass, N., Racz, A., Heckel, D., Remberger, K., Sybrecht, G. W., and Meese, E. U. Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung. Cancer Res., 57: 2290-2294, 1997.
39. Guan, X. Y., Sham, J. S., Tang, T. C., Fang, Y., Huo, K. K., and Yang, J. M. Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res., 61: 3806-3809, 2001.
40. Kobayashi, S., Okada, S., Inaba, H., Syoji, W., Hasumi, T., Sato, N., and Fujimura, S. Culture and growth characteristics of human non-small cell lung cancer cells (in Japanese). Kosankinbyo Kenkyu-Zassi, 42: 73-83, 1990.
41. Giard, D. J., Aaronson, S. A., Todaro, G. J., Arnstein, P., Kersey, J. H., Dosik, H., and Parks, W. P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. (Bethesda), 51: 1417-1423, 1973.
42. Hiraki, S., Miyai, M., Seto, T., Tamura, T., Watanabe, Y., Ozawa, S., Ikeda, H., Nakata, Y., Ohnoshi, T., and Kimura, I. Establishment of human continuous cell lines from squamous cell, adeno- and small cell carcinoma of the lung and the results of heterotransplantation. Japanese Journal of Lung Cancer, 22: 53-58, 1982.
43. Kyoizumi, S., Akiyama, M., Kouno, N., Kobuke, K., Hakoda, M., Jones, S. L., and Yamakido, M. Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis. Cancer Res., 45: 3274-3281, 1985.
44. Hirai, K., Shimada, H., Ogawa, T., and Taji, S. The spread of human lung cancer cells on collagens and its inhibition by type III collagen. Clin. Exp. Metastasis, 9: 517-527, 1991.
45. Lee, Y. C., Saijo, N., Sasaki, Y., Takahashi, H., Sakurai, M., Ishihara, J., Hoshi, A., Chen, K. M., and Hamburger, A. W. Clonogenic patterns of human pulmonary adenocarcinoma cell lines (PC-9, PC-13 and PC-14) and how they influence the results of test for chemosensitivity to cisplatin in the human tumor clonogenic assay. Jpn. J. Clin. Oncol., 15: 637-644, 1985.
46. Yamakawa, H., Baba, M., and Yamaguchi, Y. In vivo invasion assay of low passage cultured cells derived from human lung cancer using deepithelialized rat tracheas xenotransplanted into nude mice. Cancer Res., 50: 7358-7363, 1990.
47. Anger, B. R., Lloyd, K. O., Oettgen, H. F., and Old, L. J. Mouse monoclonal IgM antibody against human lung cancer line SK-LC-3 with specificity for H(O) blood group antigen. Hybridoma, 1: 139-147, 1982.
48. Appelhans, B., Ender, B., Sachse, G., Nikiforov, T., Appelhans, H., and Ebert, W. Related articles. Secretion of antileucoprotease from a human lung tumor cell line. FEBS Lett., 224: 14-18, 1987.
49. Yamashita, J., Tashiro, K., Yoneda, S., Kawahara, K., and Shirakusa, T. Local increase in polymorphonuclear leukocyte elastase is associated with tumor invasiveness in non-small cell lung cancer. Chest, 109: 1328-1334, 1996.
50. Inoue, S., Mizuno, S., Ito, M., and Ohnuma, T. Flow cytometric analyses of the characteristics of tumor cells treated with two platinum compounds: 1,1-cyclobutanedicarboxylato(2-aminomethylpyrrolidine)-platinum(II) and cisplatin. Jpn. J. Cancer Res., 83: 1231-1240, 1992.
51. Hida, T., Ariyoshi, Y., Kuwabara, M., Sugiura, T., Takahashi, T., Takahashi, T., Hosoda, K., Niitsu, Y., and Ueda, R: Glutathione S-transferase levels in a panel of lung cancer cell lines and its relation to chemo-radiosensitivity. Jpn. J. Clin. Oncol., 23: 14-19, 1993.
52. Fogh, J., Wright, W. C., and Loveless, J. D. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J. Natl. Cancer Inst. (Bethesda), 58: 209-214, 1977.